SREEDEVI YERRAPRAGADA, MD
NPI 1629076120, individual, Shreveport, LA, Internal Medicine
- Listed on the Medicare revocation list since March 15, 2022.
- Medicaid still paid claims in 1 later month, $278 in total.
Public list actions
Paid after the action
Months in which Medicaid paid claims for this provider after a public action that should have triggered a screening check. This is a record of payments, not a determination that they were improper.
| list | identity check | action date | window closed | months paid after | first | last | paid after | 12 months before |
|---|---|---|---|---|---|---|---|---|
| Medicare revocation list 424.535(a)(3) felonies | Exact NPI, name verified | Mar 15, 2022 | Mar 15, 2032 | 1 | Apr 2022 | Apr 2022 | $278 | $5K |
National provider registry
From the CMS NPPES Registry, refreshed daily.
| Name | SREEDEVI YERRAPRAGADA, MD |
| Type | Individual |
| Status | Active |
| NPI issued | July 8, 2005, last updated February 1, 2013 |
| Practice location | 2508 BERT KOUNS LOOP, SUITE 400, Shreveport, LA 71118-3133, 318-673-8320 |
| Specialties | Internal Medicine (207R00000X, primary, license 12063R LA) |
Procedures billed
The specific codes behind the dollars. Medicaid figures come from T-MSIS (2018 to 2024) and are compared with every other provider billing the same code; Medicare figures come from the 2024 physician and supplier file and compare this provider's submitted charge with what Medicare allowed, against the usual ratio for that code.
| code | what it is | paid | share | per patient-month | typical | rank among providers | |
|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | $18K | 97% | $9.41 | $60 (top 5% from $133) | 7th percentile | |
| 96372 | Injection of drug or substance under skin or into muscle | $455 | 2% | $4.33 | $12 (top 5% from $49) | 25th percentile | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | $17 | 0% | $0.41 | $0.67 (top 5% from $10) | too few months to rank | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | $15 | 0% | $1.28 | $8.88 (top 5% from $27) | too few months to rank | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | $0 | 0% | $0.00 | $0.51 (top 5% from $73) | too few months to rank | |
| G0008 | Administration of influenza virus vaccine | $0 | 0% | $0.00 | $0.25 (top 5% from $17) | too few months to rank | |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | $0 | 0% | $0.00 | $15 (top 5% from $31) | too few months to rank | |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | $0 | 0% | $0.00 | $17 (top 5% from $29) | too few months to rank |
In this area
18 providers in Caddo Parish County, LA carry an indicator in the public record, with $7.2M at stake between them. The most common is more hours than a day holds, on 10 of them, followed by part of a provider network on 4. 4 are tier 1: documented action, then payment.
| tier | provider | at stake | why |
|---|---|---|---|
| 1 | MARGARET DANIELS Shreveport, LA, ranked 342 | $3K |
|
| 1 | NORTH LOUISIANA INTERNAL MEDICINE Shreveport, LA, ranked 414 | $494 |
|
| 1 | CHARLES WERNER Shreeport, LA, ranked 415 | $494 |
|
| 1 | CHASSIDY BELL Shreveport, LA, ranked 670 | $0 |
|
| 3 | TRUCARE HOME HEALTH WEST LLC Shreveport, LA, ranked 2050 | $0 |
|
| 3 | CARSON INVESTMENTS OF LOUISIANA, INC Shreveport, LA, ranked 3592 | $0 |
|
| 3 | ARK-LA-TEX HOME HEALTH INC. Shreveport, LA, ranked 5637 | $0 |
|
| 3 | ALLEGIANCE HOSPICE CARE OF NORTHWEST LOUISIANA LLC Shreveport, LA, ranked 6696 | $0 |
|
Recent enforcement in LA
All releasesDepartment of Justice and HHS-OIG releases for this state, newest first. Each opens in a new tab.
Referral packet
The packet is a draft for a reviewer. It reads every public record behind this case, states what the records show with a citation for each finding, names the regulation each finding relates to, and lists the ordinary explanations to rule out first. It never asserts intent.